Volume 62, Issue 1, Pages (January 2015)

Slides:



Advertisements
Similar presentations
Substrates for lipid synthesis Phosphatidate is a precursor of storage and membrane lipids Formed by the addition of two fatty acids to glycerol 3-phosphate.
Advertisements

Methyl-donors choline and methionine differentially alter hepatic carbon metabolism Tawny L. Chandler, Courtney L. McCourt, Sandra J. Bertics, Barbara.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Nutritional modulation of cognitive function and mental health
Creatine supplementation prevents fatty liver in rats fed choline-deficient diet: a burden of one-carbon and fatty acid metabolism  Rafael Deminice, Gabriela.
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis  Maddalena Frau, Francesco.
Obesity and Cancer: The Oil that Feeds the Flame
Lipids in Liver Disease: Looking Beyond Steatosis
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
Sunita Sharma, MD, MPH, Augusto Litonjua, MD, MPH 
Volume 142, Issue 6, Pages (May 2012)
Nonalcoholic steatohepatitis
Sphingolipid Signaling in Metabolic Disorders
Volume 140, Issue 7, Pages (June 2011)
Figure 3 ER stress and hepatic steatosis: a vicious cycle
Volume 56, Issue 3, Pages (March 2012)
Endoplasmic reticulum stress in liver disease
Volume 55, Issue 4, Pages (October 2011)
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis  Maddalena Frau, Francesco.
Volume 124, Issue 3, Pages (March 2003)
S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility  Quentin M. Anstee, Christopher P. Day  Journal.
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Frank J. Gonzalez, Changtao Jiang, Andrew D. Patterson 
Volume 61, Issue 2, Pages (August 2014)
Is REDD1 a Metabolic Éminence Grise?
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
Mechanisms of iron hepatotoxicity
Metabolomics and Metabolic Diseases: Where Do We Stand?
Autophagy in the liver Journal of Hepatology
Volume 61, Issue 6, Pages (December 2014)
Emina Halilbasic, Thierry Claudel, Michael Trauner 
Volume 3, Issue 5, Pages (May 2006)
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
The genetics of alcohol dependence and alcohol-related liver disease
Volume 69, Issue 4, Pages (October 2018)
Innate sensors of pathogen and stress: Linking inflammation to obesity
Cannabinoid signaling and liver therapeutics
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Senescence in chronic liver disease: Is the future in aging?
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 62, Issue 6, Pages (June 2015)
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
Volume 42, Issue 6, Pages (June 2005)
A Ceramide-Centric View of Insulin Resistance
NASH animal models: Are we there yet?
Volume 61, Issue 1, Pages S79-S90 (November 2014)
miR-122 – A key factor and therapeutic target in liver disease
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Volume 61, Issue 6, Pages (December 2014)
Hong Ji, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Lipids in Liver Disease: Looking Beyond Steatosis
Volume 148, Issue 2, Pages (February 2015)
Autophagy in liver diseases: Time for translation?
Metabolic Regulation by p53 Family Members
Serine and glycine metabolism in cancer
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease  Michal Pawlak,
Volume 54, Issue 6, Pages (June 2011)
Lipid Metabolism Greases the Stem Cell Engine
Genetics of hepatocellular carcinoma: The next generation
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Using Metabolomics to Investigate Biomarkers of Drug Addiction
Sander Lefere, Frank Tacke  JHEP Reports 
Endoplasmic Reticulum Stress: At the Crossroads of Inflammation and Metabolism in Hepatocellular Carcinoma Development  Marion Maurel, Afshin Samali,
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Presentation transcript:

Volume 62, Issue 1, Pages 219-233 (January 2015) Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways  Carmen Garcia-Ruiz, Jose M. Mato, Dennis Vance, Neil Kaplowitz, José C. Fernández-Checa  Journal of Hepatology  Volume 62, Issue 1, Pages 219-233 (January 2015) DOI: 10.1016/j.jhep.2014.09.023 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 ASMase in steatohepatitis: One target, multiple pathways. ASMase becomes activated in liver samples of patients and experimental models of ASH and NASH. Recent evidence shows that ASMase is required for endoplasmic reticulum (ER) stress, autophagy and lysosomal membrane permeabilization (LMP) in ASH/NASH, which in turn mediates insulin resistance (I/R), lipogenesis, fibrosis and regulates steatosis. LMP is a novel pathway of lipotoxicity that cross-talks with mitochondria to induce apoptosis/necrosis. Moreover, ASMase activation depletes hepatic S-adenosyl-L-methionine (SAM) and phosphatidylcholine (PC), which are key intermediates in liver physiology via methylation of multiple substrates (DNA, proteins and lipids), maintenance of antioxidant and GSH defence, and membrane integrity. Thus, ASMase contributes to liver steatosis, liver injury, inflammation and fibrosis, characteristic of ASH/NASH. ASMase targeting may be a novel target of potential relevance for ASH/NASH by disabling multiple pathogenic pathways. Journal of Hepatology 2015 62, 219-233DOI: (10.1016/j.jhep.2014.09.023) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Hepatic methionine metabolism. Diet-derived methionine is transformed by MAT1A to SAM, which is then used for methylation reactions generating SAH and homocysteine. Homocysteine is remethylated to methionine by betaine or 5MTHF in reactions catalysed by BHMT and methionine synthase (MS). Betaine is derived from diet or mitochondria by diffusion following choline oxidation. MS links the methionine cycle to the folate cycle. Homocysteine escapes the methionine cycle via its transformation to cystathionine in the transsulfuration pathway, which provides cysteine for the synthesis of glutathione (GSH). SAM is transported to mitochondria to promote the methylation of mitochondrial components and the transport of GSH from cytosol by maintenance of mitochondrial membrane-fluidity. Several alterations in the methionine metabolism are associated with steatohepatitis, indicated by the red and blue arrows denoting decreases and increases, respectively. Decreased GNMT leads to increased SAM which contributes to steatohepatitis (see text for details). Journal of Hepatology 2015 62, 219-233DOI: (10.1016/j.jhep.2014.09.023) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Pathways of hepatic PC generation and role in hepatic steatosis. Liver PC is principally generated from choline via the CDP-choline arm of the Kennedy pathway. An additional pathway of PC generation is the methylation of PE by PEMT using SAM as a methyl donor. PC regulates hepatic steatosis, as PC is essential for VLDL secretion. Moreover, as shown in certain contexts, such as in the liver of LCCTα null mice, PC prevents the unconventional proteolytic processing of SREBP in the ER by proteases SP1/SP2 that lead to the activation of lipogenesis pathways. PC is a substrate for the synthesis of SM catalysed by SMS in the Golgi. PC depletion results in a secondary increase of ceramide levels. Journal of Hepatology 2015 62, 219-233DOI: (10.1016/j.jhep.2014.09.023) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Central role of ASMase in the regulation of MAT1A, PC homeostasis and lipid metabolism. Alterations in methionine metabolism, reflected as increased levels of Hcy, decreased ratio of SAM/SAH, and ASMase activation engage in a feed forward loop via the ASMase-mediated reduction of MAT1A expression. ASMase-induced generation of ceramide and sphingosine can inhibit the CDP-choline pathway of PC de novo biosynthesis, leading to decreased levels of PC. In addition, ASMase-mediated SAM depletion could contribute to decreased phosphatidylethanolamine methylation, resulting in low PC generation. ASMase activation promotes autophagy and LMP and is required for ER stress. While LMP contributes to lipotoxicity, the role autophagy in steatosis is controversial (dashed line). ER stress not only promotes lipogenesis and fatty liver via activation of the SREBP transcription factors, but regulates expression of the mitochondrial transporting protein StARD1, which stimulates cholesterol trafficking to mitochondria, contributing to oxidative stress and hepatocellular manifestations of steatohepatitis. Journal of Hepatology 2015 62, 219-233DOI: (10.1016/j.jhep.2014.09.023) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2015 62, 219-233DOI: (10. 1016/j. jhep. 2014. 09 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions